NCT03593746

Brief Summary

Diabetes has become a widespread epidemic, primarily because of the increasing prevalence and incidence of type 2 diabetes (T2D). T2D is a significant cause of premature mortality and morbidity related to cardiovascular disease, blindness, kidney and nerve disease, and amputation. Physical activity improves blood glucose control and can prevent or delay T2D, along with positively affecting lipids, blood pressure, cardiovascular events, mortality, and quality of life. At present, although physical activity is a key element in the prevention and management of T2D, the most effective exercise strategy (intensity, duration, and type of exercise) for improving glucose control and reducing cardiometabolic risk in type 2 diabetes has not been defined. Studies with Light-Emitting Diode (LED) therapy have demonstrated its ability to promote pain relief, improve muscle and cardiopulmonary performance, minimize muscle fatigue, and stimulate wound healing. In relation to patients with T2D, who have prolonged conditions of hyperglycemia, studies to investigate the impact of photobiomodulation associated with physical training have not been found so far. The objective of this study is to investigate the effects of different types of physical training associated with Light-Emitting Diode (LED) therapy on cardiometabolic status and quality of life in patients with T2D.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable diabetes-mellitus-type-2

Timeline
Completed

Started Aug 2020

Typical duration for not_applicable diabetes-mellitus-type-2

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 7, 2018

Completed
2 months until next milestone

First Posted

Study publicly available on registry

July 20, 2018

Completed
2 years until next milestone

Study Start

First participant enrolled

August 1, 2020

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2020

Completed
2.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2022

Completed
Last Updated

May 17, 2022

Status Verified

May 1, 2022

Enrollment Period

2 months

First QC Date

May 7, 2018

Last Update Submit

May 16, 2022

Conditions

Keywords

Cardiopulmonary Exercise TestRehabilitationDiabetes Mellitus, Type 2Functional CapacityPhotobiomodulation Therapy

Outcome Measures

Primary Outcomes (3)

  • Functional exercise capacity

    Oxygen consumption measurement during cardiopulmonary test

    Change from Baseline to 12 weeks

  • Incremental shuttle walking test

    Distance in meters

    Change from Baseline to 12 weeks

  • Glycemic control

    Evaluated by the percentage of glycated hemoglobin

    Change from Baseline to 12 weeks

Secondary Outcomes (7)

  • Autonomic Nervous System

    Change from Baseline to 12 weeks

  • Musculoskeletal Function

    Change from Baseline to 12 weeks

  • Physical Activity Questionnaire

    Change from Baseline to 12 weeks

  • Endothelial Function

    Change from Baseline to 12 weeks

  • Quality of Life Questionary

    Change from Baseline to 12 weeks

  • +2 more secondary outcomes

Study Arms (4)

HIIT and LED therapy

EXPERIMENTAL

Light-Emitting Diode (LED) therapy followed by physical training with high intensity interval training (HIIT)

Other: Physical trainingOther: Light-Emitting Diode (LED) therapy

High intensity interval training (HIIT)

SHAM COMPARATOR

Light-Emitting Diode (LED) therapy simulation followed by physical training with high intensity interval training (HIIT)

Other: Physical trainingOther: Light-Emitting Diode (LED) therapy

Combined training and LED therapy

EXPERIMENTAL

Light-Emitting Diode (LED) therapy followed by physical training with combined training

Other: Physical trainingOther: Light-Emitting Diode (LED) therapy

Combined training

SHAM COMPARATOR

Light-Emitting Diode (LED) therapy simulation followed by physical training with combined training.

Other: Physical trainingOther: Light-Emitting Diode (LED) therapy

Interventions

Type 2 diabetic patients will be subjected to different types of physical training (high intensity interval training or combined training).

Combined trainingCombined training and LED therapyHIIT and LED therapyHigh intensity interval training (HIIT)

Type 2 diabetic patients will be subjected to Light-Emitting Diode (LED) therapy (active or sham).

Combined trainingCombined training and LED therapyHIIT and LED therapyHigh intensity interval training (HIIT)

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 18 years;
  • Confirmed diagnosis of type 2 diabetes;
  • Sedentary lifestyle in the last six months, according to the criteria established by the American Heart Association (AHA).

You may not qualify if:

  • Confirmed diagnosis of any (1) heart disease; (2) musculoskeletal disorder; (3) respiratory disease; (4) uncontrolled arterial hypertension; (5) peripheral neuropathy or (6) factors that limit the performance of any of the study evaluations and/or training.
  • During the study, individuals with a presence of less than 80% in the training sessions will be excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UNINOVE

São Paulo, São Paulo, 03332010, Brazil

RECRUITING

Related Publications (9)

  • Bassi D, Mendes RG, Arakelian VM, Caruso FC, Cabiddu R, Junior JC, Arena R, Borghi-Silva A. Potential Effects on Cardiorespiratory and Metabolic Status After a Concurrent Strength and Endurance Training Program in Diabetes Patients - a Randomized Controlled Trial. Sports Med Open. 2016 Aug 11;2:31. doi: 10.1186/s40798-016-0052-1. eCollection 2015 Jun.

    PMID: 27563535BACKGROUND
  • Boule NG, Haddad E, Kenny GP, Wells GA, Sigal RJ. Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials. JAMA. 2001 Sep 12;286(10):1218-27. doi: 10.1001/jama.286.10.1218.

    PMID: 11559268BACKGROUND
  • Karstoft K, Winding K, Knudsen SH, Nielsen JS, Thomsen C, Pedersen BK, Solomon TP. The effects of free-living interval-walking training on glycemic control, body composition, and physical fitness in type 2 diabetic patients: a randomized, controlled trial. Diabetes Care. 2013 Feb;36(2):228-36. doi: 10.2337/dc12-0658. Epub 2012 Sep 21.

    PMID: 23002086BACKGROUND
  • Chen L, Pei JH, Kuang J, Chen HM, Chen Z, Li ZW, Yang HZ. Effect of lifestyle intervention in patients with type 2 diabetes: a meta-analysis. Metabolism. 2015 Feb;64(2):338-47. doi: 10.1016/j.metabol.2014.10.018. Epub 2014 Oct 23.

    PMID: 25467842BACKGROUND
  • Madsen SM, Thorup AC, Overgaard K, Jeppesen PB. High Intensity Interval Training Improves Glycaemic Control and Pancreatic beta Cell Function of Type 2 Diabetes Patients. PLoS One. 2015 Aug 10;10(8):e0133286. doi: 10.1371/journal.pone.0133286. eCollection 2015.

    PMID: 26258597BACKGROUND
  • Francois ME, Little JP. Effectiveness and safety of high-intensity interval training in patients with type 2 diabetes. Diabetes Spectr. 2015 Jan;28(1):39-44. doi: 10.2337/diaspect.28.1.39.

    PMID: 25717277BACKGROUND
  • Madsen SM, Thorup AC, Overgaard K, Bjerre M, Jeppesen PB. Functional and structural vascular adaptations following 8 weeks of low volume high intensity interval training in lower leg of type 2 diabetes patients and individuals at high risk of metabolic syndrome. Arch Physiol Biochem. 2015;121(5):178-86. doi: 10.3109/13813455.2015.1087033. Epub 2015 Oct 15.

    PMID: 26471849BACKGROUND
  • Gibbs BB, Dobrosielski DA, Lima M, Bonekamp S, Stewart KJ, Clark JM. The association of arterial shear and flow-mediated dilation in diabetes. Vasc Med. 2011 Aug;16(4):267-74. doi: 10.1177/1358863X11411361. Epub 2011 Jun 27.

    PMID: 21708874BACKGROUND
  • Colberg SR, Sigal RJ, Fernhall B, Regensteiner JG, Blissmer BJ, Rubin RR, Chasan-Taber L, Albright AL, Braun B; American College of Sports Medicine; American Diabetes Association. Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement executive summary. Diabetes Care. 2010 Dec;33(12):2692-6. doi: 10.2337/dc10-1548. No abstract available.

    PMID: 21115771BACKGROUND

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Interventions

Physical Conditioning, HumanTherapeutics

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

ExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Luciana MM Sampaio, Professor

    Nove de Julho University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Luciana MM Sampaio, Professor

CONTACT

Cauê Padovani, Phd

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of the postgraduate program in Rehabilitation Sciences

Study Record Dates

First Submitted

May 7, 2018

First Posted

July 20, 2018

Study Start

August 1, 2020

Primary Completion

October 1, 2020

Study Completion

December 1, 2022

Last Updated

May 17, 2022

Record last verified: 2022-05

Locations